Related Experiment Video
Updated: Oct 10, 2025

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
Published on: October 20, 2020
Addressing vaccine supply challenges in Europe: Expert industry perspective and recommendations
Muriel Pasté1, Michel Stoffel1, Corinne Bardone2
1Development of this publication; GlaxoSmithKline Biologicals, Avenue Fleming, 20, 1300 Wavre, Belgium.
Abstract:
Shortages of medicines are an increasing concern worldwide. In the European Union (EU), several initiatives have been launched by authorities to address this important public health issue. To contribute in finding solutions, Vaccines Europe (VE), representing 14 vaccine companies operating in Europe, conducted an analysis of the main root causes of vaccine shortages in Europe. Vaccines Europe has identified six main causes of vaccine shortages. Finding solutions will require a concerted effort and dialogue with the involvement of all key stakeholders. In this publication, Vaccines Europe is making a series of recommendations aiming at improving vaccine availability for Europe and beyond.
Related Concept Videos
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Control Governance: Regulatory Bodies and Their Impact
Microorganisms in Medicine and Therapeutics
Vaccinations
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

